Monte Rosa Therapeutics (GLUE) Prepaid Assets (2020 - 2026)

Monte Rosa Therapeutics (GLUE) recorded quarterly Prepaid Assets of $6.7 million in Q1 2026, up 49.92% quarter-over-quarter from $4.5 million in Q4 2025, and up 40.02% on a YoY basis from $4.8 million in Q1 2025.

Monte Rosa Therapeutics (GLUE) Prepaid Assets (2020 - 2026) Analysis & Trends

Monte Rosa Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $6.7 million for Q1 2026.

  • In Q1 2026, Prepaid Assets rose 40.02% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (up 40.02% YoY), while the FY2025 annual figure was $4.5 million, down 12.45% from the prior year.
  • Prepaid Assets was $6.7 million for Q1 2026 at Monte Rosa Therapeutics, up from $4.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.4 million in Q3 2024 to a low of $2.9 million in Q2 2022.
  • Historically, Prepaid Assets has averaged $5.0 million across 5 years, with a median of $4.8 million in 2025.
  • The sharpest annual moves came in 2022 and 2025: Prepaid Assets surged 135.96% in 2022, then tumbled 33.61% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $4.4 million in 2022, then fell by 25.88% to $3.3 million in 2023, then jumped by 55.37% to $5.1 million in 2024, then slipped by 12.45% to $4.5 million in 2025, then jumped by 49.92% to $6.7 million in 2026.
  • The last three Prepaid Assets figures came in at $6.7 million (Q1 2026), $4.5 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Monte Rosa Therapeutics 1.83 Bn 1.15 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.72 Mn
Dec 31, 2025 4.48 Mn
Sep 30, 2025 5.59 Mn
Jun 30, 2025 6.50 Mn
Mar 31, 2025 4.80 Mn
Dec 31, 2024 5.12 Mn
Sep 30, 2024 8.43 Mn
Jun 30, 2024 5.85 Mn
Mar 31, 2024 5.54 Mn
Dec 31, 2023 3.29 Mn
Sep 30, 2023 4.14 Mn
Jun 30, 2023 3.88 Mn
Mar 31, 2023 5.69 Mn
Dec 31, 2022 4.44 Mn
Sep 30, 2022 4.57 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 3.20 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 3.49 Mn
Jun 30, 2021 1.23 Mn